Walmart stock maintains Buy rating at BofA on strong grocery performance

Bank of America Securities reiterated its Buy rating and $120 price target for Walmart, citing robust performance across key retail segments including mid-single digit grocery comparable sales growth and improved general merchandise. While Walmart's Q2 adjusted EPS of $0.68 missed analyst expectations due to higher claims costs, revenue reached $177.4 billion, surpassing forecasts. Analysts, including Raymond James and Morgan Stanley, maintained positive outlooks and price targets, underscoring confidence in Walmart's continued market share gains driven by its value proposition and expanded assortments despite the mixed quarterly results.

Analysis

Walmart's recent performance presents a compelling case of robust top-line growth and market share expansion, even as bottom-line results faced a temporary setback. The company achieved a Q2 revenue of $177.4 billion, surpassing market forecasts, driven by broad-based strength across its core segments. Grocery comparable sales saw mid-single-digit growth on top of a strong prior year, supported by Walmart's low grocery inflation of approximately 1.5%. General merchandise sales improved to low-single-digit growth from a previously flat or slightly negative performance, and the health and wellness segment accelerated to mid-teens growth. This momentum, indicative of successful market share gains through value offerings and expanded assortments, has anchored positive ratings from multiple investment banks like Bank of America, which reiterated a Buy rating and a $120 price target. However, this top-line strength was contrasted by a miss on profitability, with Q2 adjusted EPS of $0.68 falling short of expectations due to higher-than-anticipated claims costs impacting EBIT. Despite this earnings miss, the overwhelming analyst consensus remains positive, focusing on the strong revenue trajectory and fundamental business health.

Key Decisions for Investors

• Investors should weigh the strong revenue beat and market share gains across all segments against the Q2 earnings miss, which analysts appear to be treating as a transient issue rather than a fundamental flaw.
• Monitor future quarterly reports for commentary on the "higher claims costs" to ascertain if this is a one-off impact on profitability or a recurring headwind that could temper future earnings growth.
• Given the stock is trading near its 52-week high but analyst price targets remain significantly higher, a hold or buy-on-dip strategy could be considered for those confident in the long-term revenue growth narrative, while acknowledging potential for short-term volatility from the recent earnings miss.